Distribution kinetics of opioids used in substitution programs
替代计划中使用的阿片类药物的分布动力学
基本信息
- 批准号:nhmrc : 157942
- 负责人:
- 金额:$ 13.1万
- 依托单位:
- 依托单位国家:澳大利亚
- 项目类别:NHMRC Project Grants
- 财政年份:2001
- 资助国家:澳大利亚
- 起止时间:2001-01-01 至 2003-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Heroin addiction is a major national and international problem costing hundreds of millons of dollars to Australia alone. The major form of treatment is methadone taken as maintenance treatment once a day. While methadone is effective in most addicts, about one third of them complain that it does not last long enough and they either tolerate this inadequate form of treatment or are prescribed a newer drug as part of a clinical trial or drop out and revert to heroin. We have previously shown that the blood levels of methadone are important in determining its best use and specifically, that those addicts for whom methadone does not hold have a greater drop in their blood levels after methadone has been absorbed into the body. This drop in blood levels is mainly due to methadone's redistribution throughout the body. Very little is known about how methadone distributes and redistributes throughout the body but it appears that the lung is the most important organ. A number of questions need to be answered to improve methadone's use: 1. How quickly is methadone taken up into the lung compared to the brain; 2. Why is the lung able to take up and release a large amount of methadone; 3. How does decreased respiration influence the lung and brain uptake of methadone; 4. What happens when another drug is prescribed (such as an antidepressant) which reduces the lung uptake of methadone; 5. Do some of the newer drugs for heroin addiction have better lung distribution and binding properties. We will perform studies of the concentrations of methadone and newer drugs in sheep that will provide the scientific basis for answering these questions and permit better use of drug treatment for heroin addiction.
海洛因成瘾是一个主要的国家和国际问题,仅在澳大利亚就造成了数亿美元的损失。主要的治疗形式是美沙酮作为维持治疗,每天一次。虽然美沙酮对大多数成瘾者有效,但约有三分之一的人抱怨药效持续时间不够长,他们要么忍受这种不适当的治疗方式,要么作为临床试验的一部分被开一种新药,要么退出治疗,重新吸食海洛因。我们之前的研究表明,美沙酮的血液水平对决定其最佳使用效果很重要,特别是那些美沙酮无效的成瘾者,在美沙酮被人体吸收后,其血液水平的下降幅度更大。这种血液水平的下降主要是由于美沙酮在全身的重新分配。我们对美沙酮在体内的分布和再分布知之甚少,但似乎肺是最重要的器官。为了改善美沙酮的使用,需要回答以下几个问题:与大脑相比,美沙酮进入肺部的速度有多快;2. 为什么肺能够吸收并释放大量的美沙酮?3. 呼吸减少如何影响肺和脑对美沙酮的吸收;4. 当另一种药物(如抗抑郁药)减少肺部对美沙酮的吸收时会发生什么?5. 一些新的海洛因成瘾药物是否有更好的肺分布和结合特性?我们将对绵羊体内美沙酮和新药的浓度进行研究,这将为回答这些问题提供科学依据,并允许更好地使用药物治疗海洛因成瘾。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Prof Andrew Somogyi其他文献
Prof Andrew Somogyi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Prof Andrew Somogyi', 18)}}的其他基金
TIR Signalling Pathway Pharmacogenomics and Opioid Response: beyond the mu opioid receptor
TIR 信号通路药物基因组学和阿片类药物反应:超越 mu 阿片类药物受体
- 批准号:
nhmrc : 1011521 - 财政年份:2011
- 资助金额:
$ 13.1万 - 项目类别:
Project Grants
The cognitive impact of opioids during chronic administration
长期服用阿片类药物对认知的影响
- 批准号:
nhmrc : 565410 - 财政年份:2009
- 资助金额:
$ 13.1万 - 项目类别:
NHMRC Project Grants
Mu Opioid Receptor Polymorphisms and Variability in Opioid Actions
Mu 阿片受体多态性和阿片类药物作用的变异性
- 批准号:
nhmrc : 299050 - 财政年份:2004
- 资助金额:
$ 13.1万 - 项目类别:
NHMRC Project Grants
Population pharmacokinetics and pharmacodynamics of methadone for opioid substitution.
美沙酮替代阿片类药物的群体药代动力学和药效学。
- 批准号:
nhmrc : 990586 - 财政年份:1999
- 资助金额:
$ 13.1万 - 项目类别:
NHMRC Project Grants
相似国自然基金
基于Hydrodynamics-Reaction Kinetics耦合模型的厌氧膨胀床反应器三相流场数值模拟及生态-水力响应机制解析
- 批准号:51078108
- 批准年份:2010
- 资助金额:36.0 万元
- 项目类别:面上项目
水合物储存氢气的应用基础研究
- 批准号:50806050
- 批准年份:2008
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Elucidating the role of the endogenous opioid dynorphin in reward seeking
阐明内源性阿片类强啡肽在寻求奖励中的作用
- 批准号:
10722734 - 财政年份:2023
- 资助金额:
$ 13.1万 - 项目类别:
A novel microfluidic system for studying brain chemistry and application to study of enkephalin-degrading enzymes in pain perception
一种用于研究脑化学的新型微流体系统及其在疼痛感知中脑啡肽降解酶研究中的应用
- 批准号:
10504385 - 财政年份:2022
- 资助金额:
$ 13.1万 - 项目类别:
Uncovering the roles of oxysterols in neuropathic pain
揭示氧甾醇在神经性疼痛中的作用
- 批准号:
10659247 - 财政年份:2022
- 资助金额:
$ 13.1万 - 项目类别:
Antibody-based countermeasures against fentanyl and its analogues
基于抗体的芬太尼及其类似物对策
- 批准号:
10598994 - 财政年份:2022
- 资助金额:
$ 13.1万 - 项目类别:
Domain-specific inhibition of angiotensin-converting enzyme as a therapeutic strategy for opioid use disorders
血管紧张素转换酶的域特异性抑制作为阿片类药物使用障碍的治疗策略
- 批准号:
10512191 - 财政年份:2022
- 资助金额:
$ 13.1万 - 项目类别:
Title: Pharmacokinetic, pharmacodynamic , and toxicological interactions among Opioids and Cabotegravir
标题:阿片类药物和卡博特韦之间的药代动力学、药效学和毒理学相互作用
- 批准号:
10686187 - 财政年份:2022
- 资助金额:
$ 13.1万 - 项目类别:
Perioperative Precision Medicine: Translating Science to Clinical Practice to Improve Safety and Efficacy of Opioids in Neonates, Children and Nursing Mothers
围手术期精准医学:将科学转化为临床实践,提高阿片类药物对新生儿、儿童和哺乳期母亲的安全性和有效性
- 批准号:
10676237 - 财政年份:2022
- 资助金额:
$ 13.1万 - 项目类别:
Title: Pharmacokinetic, pharmacodynamic , and toxicological interactions among Opioids and Cabotegravir
标题:阿片类药物和卡博特韦之间的药代动力学、药效学和毒理学相互作用
- 批准号:
10548530 - 财政年份:2022
- 资助金额:
$ 13.1万 - 项目类别:
Uncovering the roles of oxysterols in neuropathic pain
揭示氧甾醇在神经性疼痛中的作用
- 批准号:
10504409 - 财政年份:2022
- 资助金额:
$ 13.1万 - 项目类别:
A novel microfluidic system for studying brain chemistry and application to study of enkephalin-degrading enzymes in pain perception
一种用于研究脑化学的新型微流体系统及其在疼痛感知中脑啡肽降解酶研究中的应用
- 批准号:
10647766 - 财政年份:2022
- 资助金额:
$ 13.1万 - 项目类别:














{{item.name}}会员




